Know Your Force: Study Shows Value Of Contact-Force-Sensing Ablation Catheter
This article was originally published in The Gray Sheet
Executive Summary
Results of the first major trial evaluating Biosense Webster’s contact-force-sensing ThermoCool SmartTouch catheter show that stability of contact between the ablation catheter and the ablated tissue substantially improves the effectiveness of cardiac ablation for atrial fibrillation, but the average contact force applied during the procedure does not appear to make a difference.
You may also be interested in...
News Briefs: FDA Approves AF Catheter; Tax Reform Proposal; Renal Denervation
FDA approved a PMA supplement for Biosense Webster’s Thermocool SmartTouch, the first FDA-approved ablation catheter that can measure contact force in real time. J&J earns a CE mark for its Renlane renal denervation system. More news briefs.
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.